Your session is about to expire
← Back to Search
Pain Management After VATS for Postoperative Pain
Study Summary
This trial is looking for the best way to manage pain after VATS surgery, which is a minimally-invasive surgery for lung conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe liver disease.I am between 18 and 79 years old.My blood does not clot properly.I am scheduled for a minimally invasive chest surgery.I have had a surgery to fuse my lung lining using a camera-assisted technique.I have long-term chronic pain.I am tolerant to opioids.My BMI is over 40.Currently in prison.I am unable to understand or sign the consent form.I do not speak English.You are allergic to the study medication.I have an infectious disease.I have chronic pain conditions like fibromyalgia or nerve pain in my chest area.You weigh less than 40 times your height in kilograms.
- Group 1: Liposomal bupivacaine
- Group 2: Bupivacaine
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the current research project open to enrollment of individuals over 55 years old?
"The participant requirements for this trial necessitate that patients must be over 18 yet under 80 years of age."
How many participants are currently participating in this clinical trial?
"Affirmative, according to clinicaltrials.gov this medical study is currently recruiting participants. It was initially posted on February 2nd 2021 and recently updated on September 19th 2022, with a total of 128 patients being sought from one single site."
What aims is this medical experiment hoping to achieve?
"The primary outcome of this research is to assess post-operative acute pain scores up to 72 hours after the procedure. Secondary objectives include measuring lung function using an incentive spirometer device, tracking opioid consumption following hospital discharge, and determining total length of hospital stay. The air volume inhaled will be graded on a scale from 0 - 2500 milliliters with higher values indicating greater respiratory function compared to baseline measurements before surgery."
To what extent am I eligible to join in this research experiment?
"This clinical trial is seeking 128 individuals with postoperative pain aged between 18 and 80. Notably, prospective participants must be over the age of consent, possess a body mass index below 40, and undergo video-assisted thoracoscopic surgery (VATS)."
Have any other studies been conducted involving Liposomal bupivacaine?
"Currently, 108 studies are evaluating the efficacy of Liposomal bupivacaine. 18 trials have reached Phase 3 status and they are being conducted in 143 locations primarily based around Philadelphia, Pennsylvania."
Has the Federal Drug Administration given their stamp of approval to Liposomal bupivacaine?
"Liposomal bupivacaine is rated a 2 on the safety scale, as clinical data supports its safety but there is no evidence of efficacy yet."
Are there any available vacancies for potential participants in this experiment?
"That is correct. According to clinicaltrials.gov, this medical trial has been recruiting patients since February 2nd 2021 and the listing was recently updated on September 19th 2022. 128 participants are being sought from a single site for this experiment."
For what conditions has Liposomal bupivacaine been prescribed?
"Liposomal bupivacaine is a commonly-prescribed treatment for permphigus, as well as acute nonspecific tenosynovitis, general anesthesia, and lupus erythematosus cell."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger